U.S. Markets open in 8 hrs 25 mins

Cara Therapeutics, Inc. (CARA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
13.34-0.39 (-2.84%)
At close: 4:00PM EDT
Sign in to post a message.
  • E
    Now fully loaded with 7140 shares people are gonna kick themselves for not loading up at this firesale. CARA secondary offering and Fresenius SP were higher. A solid drug that is highly efficacious and safe to treat I.V. itching right up the alley where Fresenius is. NDA and approval thereafter a slam dunk deriaked event for an unmet medical need. People having average $$$ Of below 20$ if they have the patience will profit in my opinion. The o ly risk besides their ph2 awaited results I seriously can’t think of anything else and of course raising more money but that goes without saying in any clinical development name me another low cap bio with better benefit to risk. Good luck bulls just stay patient day to day SP activity means squat to me this is all about NDA filing and hopefully BO ensuing thereafter.
  • J
    Should I be worried?

    Forte Biosciences is progressing well with Atopic Dermatitis including Pruritis


    Kiniksa is progressing nicely with a treatment for Pruritis across ALL indications
  • m
    Large international company buying them out. The announced closing will be 30 to 60 days from now. Price already starting to move up and very soon could spike big on announcement.
    Reverse Merger Underway With Protect Pharmaceutical Corp And Novgorod Would Increase PRTT Sales, Assets, And Growth Dramatically - BioResearch Alert
  • B
    Seems they have only one product, right?
  • r
    Both these companies mentioned as possible competitors are WAY behind CARA and as far as I can tell don't have a partner the caliber of Fresenius. Interesting that Forte's market cap is that close the CARA's but I think that CARA being labeled a cannabis company hurts our share price.
  • L
    Why is it falling?
  • E
    I like this company a lot after extensive DD started a small 3k position average $15.30. Easy one bagger in a few months my PT selling point is between 25-30$. Very undervalued stock considering how unique the effects of the drug is.
  • W
    William H.
    CARA is still in the computers(65%of all trading) as a marijuana stock CGC TLRY CRON MJ and CARA price charts are almost identical. BUT MR market will shortly reclassify as a drug stock perhaps as KORSUVA NDA is submitted
  • J
    So Chris - oh wise one
    Please answer this question
    You are correct Cara can’t seem to keep any gains and it seems like this started in earnest when they didn’t neet secondary endpoints in Korsuva oral kidney trials
    So now- do you think they will ever break out of their narrow trading range and stay up and what will it take ?
  • S
    Same price it was 5 years ago. Like a zero % savings account
  • T
    CARA seems to be holding on amidst some situation in the market right now. Also, this company is anticipating to have its own promising name in the cannabis market. More details here: https://shr.link/BestCannabisStocks
    Companies With Leading licensed cannabis producer in Canada!
    Companies With Leading licensed cannabis producer in Canada!
  • s
    Sold 1,000 shares at $19 in after hours wish I sold my other 6,000 shares. Never holds any gains
  • J
    I never wanted to get political but when we solve Covid things will slowly get back to normal but if the current situation continues we are all in trouble

    And if you really want to help people with employment you allocate a trillion to infra structure not tax cuts

    Sorry for the political comments
  • Y
    Yahoo Finance Insights
    Cara Therapeutics is up 6.48% to 18.33
  • S
    Hello? Usually works to buy CARA here at long term support for a nice trade
  • M
    I started following "lionstock-aletrs” (Gooogle it - off course without any space or dash in between the words) and their notifications are better than anyone else.
  • C
    Sell Sell Sell.
  • J
    Stop it It?s going nowhere until they get positive results from studies This rise today is #$%$
  • p
    Thursday @ Canaccord Genuity 40th Annual Growth Conference ,Hope we have Good News!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
  • A
    When are AD Phase 2 results expected now?When do we expect NDA submittal and FDA decision for IV application of pruritus #$%$ociated with CKD?Guessing first half 2021 for both? I haven?t been paying attention lately, yawn.